Abiraterone 250mg Tablet Celbira

Abiraterone 250mg Tablet Celbira is a hormone replacement therapy medication. It’s a prostate cancer treatment. If other hormone treatments have failed and you have no or moderate symptoms but do not require chemotherapy, you may have abiraterone.

Abiraterone 250mg Tablet Celbira has been shown in trials to increase life expectancy. In the larger research, around 50 out of 100 men who received standard treatment were still living after three years, while 70 out of 100 men who received abiraterone acetate treatment were still alive after the same time period.

Abiraterone is available as a tablet to be taken by mouth with water on an empty stomach 1 hour before or 2 hours after consuming any food. It’s often taken once or twice daily. Every day, around the same time, take abiraterone.

• Consequences
• Bladder discomfort.
• Face, arms, hands, lower legs, or foot bloating or swelling
• Urine that is crimson or cloudy.
• Fracture or bone discomfort
• Pain or discomfort in the chest.
• urinary incontinence
• Urination that is difficult, scorching, or painful.
• Heartbeat or pulse that is rapid, hammering, or erratic.  For more details

Prostate cancer is treated using this drug. Anti-androgens are a class of medications that include abiraterone (anti-testosterone)Testosterone, a natural hormone, promotes prostate cancer growth and spread.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

If abiraterone isn’t right for you or you don’t want to take it, your doctor may suggest another option. Other options for treatment if you’ve just been diagnosed with advanced prostate cancer include chemotherapy and hormone therapy. hormone treatment isn’t enough.

Check this Anti Cancer product  Abiraterone 250 mg Tablet Abiron or you may explore more Anti Cancer products  by clicking here

We are an exporter from India and work in excess countries like the UAE, Oman, Qatar, Myanmar, Saudi Arabia, Netherlands, Albania, Saint Lucia, Jordan, Romania, South Africa, etc.